1337 related articles for article (PubMed ID: 21712404)
1. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
; Reiner Z; Catapano AL; De Backer G; Graham I; Taskinen MR; Wiklund O; Agewall S; Alegria E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Filardi PP; Riccardi G; Storey RF; Wood D;
Eur Heart J; 2011 Jul; 32(14):1769-818. PubMed ID: 21712404
[TBL] [Abstract][Full Text] [Related]
2. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
; Catapano AL; Reiner Z; De Backer G; Graham I; Taskinen MR; Wiklund O; Agewall S; Alegria E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Perrone Filardi P; Riccardi G; Storey RF; Wood D;
Atherosclerosis; 2011 Jul; 217 Suppl 1():S1-44. PubMed ID: 21723445
[No Abstract] [Full Text] [Related]
3. ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
Catapano AL; Reiner Z; De Backer G; Graham I; Taskinen MR; Wiklund O; Agewall S; Alegria E; Chapman M; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Filardi PP; Riccardi G; Storey RF; Wood D; ;
Atherosclerosis; 2011 Jul; 217(1):3-46. PubMed ID: 21882396
[No Abstract] [Full Text] [Related]
4. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR).
; Catapano AL; Graham I; De Backer G; Wiklund O; Chapman MJ; Drexel H; Hoes AW; Jennings CS; Landmesser U; Pedersen TR; Reiner Ž; Riccardi G; Taskinen MR; Tokgozoglu L; Verschuren WM; Vlachopoulos C; Wood DA; Zamorano JL
Atherosclerosis; 2016 Oct; 253():281-344. PubMed ID: 27594540
[No Abstract] [Full Text] [Related]
5. The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011.
Ray KK; Kastelein JJ; Boekholdt SM; Nicholls SJ; Khaw KT; Ballantyne CM; Catapano AL; Reiner Ž; Lüscher TF
Eur Heart J; 2014 Apr; 35(15):960-8. PubMed ID: 24639424
[TBL] [Abstract][Full Text] [Related]
6. [2016 ESC/EAS Guidelines for the Management of Dyslipidaemias].
Catapano AL; Graham I; De Backer G; Wiklund O; Chapman MJ; Drexel H; Hoes AW; Jennings CS; Landmesser U; Pedersen TR; Reiner Ž; Riccardi G; Taskinen MR; Tokgozoglu L; Verschuren WM; Vlachopoulos C; Wood DA; Zamorano JL
Kardiol Pol; 2016; 74(11):1234-1318. PubMed ID: 27910077
[No Abstract] [Full Text] [Related]
7. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk.
; ;
Atherosclerosis; 2019 Nov; 290():140-205. PubMed ID: 31591002
[No Abstract] [Full Text] [Related]
8. Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions.
Kotseva K; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Abreu A; Aguiar C; Conde AC; Davletov K; Dilic M; Dolzhenko M; Gaita D; Georgiev B; Gotcheva N; Lalic N; Laucevicius A; Lovic D; Mancas S; Miličić D; Oganov R; Pajak A; Pogosova N; Reiner Ž; Vulic D; Wood D; On Behalf Of The Euroaspire Investigators
Eur J Prev Cardiol; 2016 Dec; 23(18):2007-2018. PubMed ID: 27638542
[TBL] [Abstract][Full Text] [Related]
9. Assessment of application of the new 2019 European Society of Cardiology/ European Atherosclerosis Society Guidelines for the Management of Dyslipidaemias in daily clinical practice - one center study.
Cecha P; Chromik A; Piotrowska I; Zabojszcz M; Dolecka-Ślusarczyk M; Siudak Z
Folia Med Cracov; 2021 Sep; 61(3):43-54. PubMed ID: 34882663
[TBL] [Abstract][Full Text] [Related]
10. Comparison of four international cardiovascular disease prediction models and the prevalence of eligibility for lipid lowering therapy in HIV infected patients on antiretroviral therapy.
Begovac J; Dragović G; Višković K; Kušić J; Perović Mihanović M; Lukas D; Jevtović Đ
Croat Med J; 2015 Feb; 56(1):14-23. PubMed ID: 25727038
[TBL] [Abstract][Full Text] [Related]
11. 'Diet and lifestyle' in the management of dyslipidaemia and prevention of CVD - Understanding the level of knowledge and interest of European Atherosclerosis Society members.
Trautwein EA; Catapano AL; Tokgözoğlu L
Atheroscler Suppl; 2020 Dec; 42():e9-e14. PubMed ID: 33589228
[TBL] [Abstract][Full Text] [Related]
12. [A perspective to lipid lowering therapy after ESC/EAS guidelines for the management of dyslipidaemias and the European guidelines on cardiovascular disease prevention in clinical practice].
Ural D
Turk Kardiyol Dern Ars; 2012 Jun; 40(4):293-7. PubMed ID: 22951844
[No Abstract] [Full Text] [Related]
13. New ESC/EAS Guidelines for the management of dyslipidaemias - any controversies behind the consensus?
Reiner Z
Eur J Cardiovasc Prev Rehabil; 2011 Oct; 18(5):724-7. PubMed ID: 21945917
[No Abstract] [Full Text] [Related]
14. [ESC/EAS Guidelines for the management of dyslipidaemias].
Reiner Ž; Catapano AL; De Backer G; Graham I; Taskinen MR; Wiklund O; Agewall S; Alegría E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs RH; Kjekshus JK; Perrone Filardi P; Riccardi G; Storey RF; David W;
Rev Esp Cardiol; 2011 Dec; 64(12):1168.e1-1168.e60. PubMed ID: 22115524
[No Abstract] [Full Text] [Related]
15. Nutrition and physical activity recommendations from the United States and European cardiovascular guidelines: a comparative review.
Ferraro RA; Fischer NM; Xun H; Michos ED
Curr Opin Cardiol; 2020 Sep; 35(5):508-516. PubMed ID: 32649350
[TBL] [Abstract][Full Text] [Related]
16. A contemporary cross-sectional study on dyslipidemia management, cardiovascular risk status, and patients' quality of life in Greece: The CHALLENGE study.
Alexopoulos D; Anastasiou-Nana M; Elisaf MS; Liberopoulos E; Rallidis LS; Davos CH; Moulis A; Nikas N; Zacharis E; Vardas P;
Int J Cardiol; 2016 Aug; 217():183-9. PubMed ID: 27183455
[TBL] [Abstract][Full Text] [Related]
17. [ECS guidelines 2016 - dyslipidaemias].
Sinning D; Landmesser U
Herz; 2016 Dec; 41(8):671-676. PubMed ID: 27844136
[TBL] [Abstract][Full Text] [Related]
18. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.
Catapano AL; Graham I; De Backer G; Wiklund O; Chapman MJ; Drexel H; Hoes AW; Jennings CS; Landmesser U; Pedersen TR; Reiner Ž; Riccardi G; Taskinen MR; Tokgozoglu L; Verschuren WMM; Vlachopoulos C; Wood DA; Zamorano JL; Cooney MT;
Eur Heart J; 2016 Oct; 37(39):2999-3058. PubMed ID: 27567407
[No Abstract] [Full Text] [Related]
19. New concepts in the management of dyslipidaemiaa.
Gencer B; Rodondi N; Mach F
Swiss Med Wkly; 2016; 146():w14378. PubMed ID: 27878791
[TBL] [Abstract][Full Text] [Related]
20. Proportion of High-Risk/Very High-Risk Patients in Europe with Low-Density Lipoprotein Cholesterol at Target According to European Guidelines: A Systematic Review.
Bruckert E; Parhofer KG; Gonzalez-Juanatey JR; Nordestgaard B; Arca M; Giovas P; Ray K
Adv Ther; 2020 May; 37(5):1724-1736. PubMed ID: 32200537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
